Corporate insider
Thomas John Charles
EVP, General CounselCIK 0002114900
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score20
Connections with evidence1
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Thomas John CharlesEVP, General Counsel |  KRYSKrystal Biotech, Inc.Option exercise · 10b5-1 plan | M | — 1,000 sh | Jun 26, 2026 traded Jun 25, 2026 | |
Verified connections
- Insider ofevidenceKrystal Biotech, Inc.EVP, General Counsel · May 27, 2026